Aer Therapeutics
Raleigh
About Aer Therapeutics
Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $41.0M
- Last round: Series Unknown (Feb 2025)
- Website: aertherapeutics.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aer-therapeutics-18435 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.